According to our latest research, the ankylosing spondylitis market size reached USD 5.1 billion in 2024, reflecting sustained demand for advanced therapeutics and increased diagnosis rates worldwide. The market is projected to grow at a robust CAGR of 7.2% from 2025 to 2033, positioning the global market to achieve a value of approximately USD 9.6 billion by 2033. This growth is driven by rising disease prevalence, expanding access to biologics, and ongoing innovation in targeted therapies.
https://growthmarketreports.com/report/ankylosing-spondylitis-market-global-industry-analysis
https://growthmarketreports.com/report/ankylosing-spondylitis-market-global-industry-analysis
According to our latest research, the ankylosing spondylitis market size reached USD 5.1 billion in 2024, reflecting sustained demand for advanced therapeutics and increased diagnosis rates worldwide. The market is projected to grow at a robust CAGR of 7.2% from 2025 to 2033, positioning the global market to achieve a value of approximately USD 9.6 billion by 2033. This growth is driven by rising disease prevalence, expanding access to biologics, and ongoing innovation in targeted therapies.
https://growthmarketreports.com/report/ankylosing-spondylitis-market-global-industry-analysis